Natixis Advisors LLC Sells 3,604 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
Natixis Advisors LLC decreased its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 13.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,554 shares of the biopharmaceutical company’s stock after selling 3,604 shares during the period. Natixis Advisors LLC’s […]
Natixis Advisors LLC decreased its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 13.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 23,554 shares of the biopharmaceutical company’s stock after selling 3,604 shares during the period. Natixis Advisors LLC’s […]
